-transparent.png){kind=logo}
Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation. 2020
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), REBIRTH-Research Center for Translational and Regenerative Medicine, Hannover Medical School, 30625 Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Member of the German Center for Lung Research (DZL), 30625 Hannover, Germany. Electronic address: merkert.sylvia@mh-hannover.de.
Cystic Fibrosis (CF) is a genetic disease caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene which encodes for a chloride ion channel regulating the balance of salt and water across secretory epithelia. Here we generated an iPSC line from a CF patient homozygous for the p.Asn1303Lys mutation, a Class II folding defect mutation. This iPSC line provides a useful resource for disease modeling and to investigate the pharmacological response to CFTR modulators in iPSC derived epithelia.
Related Publications
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
July 2022,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
August 2021,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
October 2020,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
December 2024,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
July 2022,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
April 2022,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
May 2021,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
October 2024,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
April 2023,
Stem cell research,
Sylvia Merkert, and
Madline Schubert, and
Alexandra Haase, and
Hettie M Janssens, and
Bob Scholte, and
Nico Lachmann, and
Gudrun Göhring, and
Ulrich Martin
March 2023,
Stem cell research,
